IP Verse

Schering Corporation opposition analysis

COMPANY ANALYSIS

Patent:

Grant Date:

Apr 29, 2020

Title:

Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral Polymerase

Oppositions:

Patent:

Grant Date:

Nov 8, 2017

Title:

Use Of Il-33 Antagonists To Treat Fibrotic Disease

Oppositions:

Patent Number	Grant Date	Title	Total Oppositions
EP2399588	Apr 29, 2020	Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral Polymerase	1
EP2475388	Nov 8, 2017	Use Of Il-33 Antagonists To Treat Fibrotic Disease	1

ELI LILLY AND COMPANY

GILEAD SCIENCES, INC.

Feel free to send us a message here and we will get back to you